Share.

    3 Kommentare

    1. Gives me Hope that one day Cancer won’t be anything else than a crustacean

    2. The end of the text reads: The antibody 04_A06 has been exclusively licensed to Vir Biotechnology, Inc.

      Prof. Florian Klein, Director of the Institute of Virology at Cologne University Hospital, coordinator of the bridging topic “Antibody-Based Therapies” at the German Center for Infection Research (DZIF) and head of the study, emphasizes the international significance of the collaboration: “The success of this work relied on close collaboration with study centres in Africa, Nepal, and the USA. The next step is to further test the antibody’s safety and efficacy in clinical trials, thus paving its way to patient care.”

      The study was supported by the Gates Foundation in furtherance of its charitable purposes, the German Research Foundation (DFG), the German Center for Infection Research (DZIF) and the European Research Council (ERC).

      LOL

    Leave A Reply